{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:32:11Z","timestamp":1788849131788,"version":"build-2803163510"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,12]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Uterine carcinosarcoma (UCS) is a rare and highly invasive malignant tumor.It exhibits an ectopic growth pattern of the uterus,and its histological features are biphasic differentiation of malignant epithelial components (cancer) and malignant mesenchymal components (sarcoma). The pathological pattern of high-component neuroendocrine differentiation is extremely rare. Due to the inherent heterogeneity of tumors, it increases the difficulty of accurate identification and diagnosis. The author introduces a rare case of primary endometrial carcinosarcoma (heterologous) with small cell neuroendocrine carcinoma (SCNEC) components. There is limited literature on this rare pathological differentiation pattern and a lack of guidelines for the best treatment methods, which prompts reflection on the diagnosis, optimal treatment strategies, and how preoperative diagnosis can affect patient prognosis for endometrial carcinosarcoma with neuroendocrine differentiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>The patient is an elderly woman who presents with abnormal vaginal bleeding after menopause. Transvaginal ultrasound examination shows that the uterus is slightly enlarged, and there is a lack of homogeneous echogenicity in the uterine cavity. Subsequently, a hysteroscopic curettage was performed, and a space-occupying lesion was observed on the anterior wall of the uterine cavity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Preoperative endometrial biopsy revealed SCNEC of the endometrium. The patient underwent radical hysterectomy, and the postoperative pathological results showed that UCS (heterologous) was accompanied by SCNEC components (about 80%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention:<\/jats:title>\n                    <jats:p>The patient received radical hysterectomy, followed by adjuvant chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome:<\/jats:title>\n                    <jats:p>After 7 months of follow-up, no tumor recurrence or metastasis was found at the time of writing this article.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>The histological type of UCS (heterologous) with cell neuroendocrine carcinoma components is rare and highly invasive, with a high misdiagnosis rate in preoperative biopsy. There are currently no effective treatment guidelines for this type of case. The unusual appearance of SCNEC components in this case poses a challenge for both pathologists and surgeon. The rare differentiation pattern of this case exposes the complexity of its management and the necessity of prospective trials to determine the optimal treatment plan.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000038800","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T15:04:49Z","timestamp":1720796689000},"page":"e38800","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Unexpected rare uterine carcinosarcoma with neuroendocrine differentiation: Reflections on clinical diagnosis and treatment of a case report"],"prefix":"10.1097","volume":"103","author":[{"given":"Qichong","family":"Shi","sequence":"first","affiliation":[{"name":"Department of General Surgery, The Fifth People\u2019s Hospital of Huaian, Yangzhou University Huaian, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longmei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Fifth People\u2019s Hospital of Huaian, Yangzhou University Huaian, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2218-8862","authenticated-orcid":false,"given":"Juan","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Fifth People\u2019s Hospital of Huaian, Yangzhou University Huaian, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260204","doi-asserted-by":"crossref","first-page":"103369","DOI":"10.1016\/j.critrevonc.2021.103369","article-title":"Uterine carcinosarcoma: an overview.","volume":"163","author":"Pezzicoli","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"R2-20260204","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ygyno.2021.05.003","article-title":"Uterine carcinosarcomas: from pathology to practice.","volume":"162","author":"Toboni","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R3-20260204","doi-asserted-by":"crossref","first-page":"20363613211010876","DOI":"10.1177\/20363613211010876","article-title":"Nature and significance of stromal differentiation in carcinosarcoma (MMMT): unravelling the biology and shifting current paradigms.","volume":"13","author":"Hacking","year":"2021","journal-title":"Rare Tumors"},{"key":"R4-20260204","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3390\/medicina57121338","article-title":"Emerging therapeutic concepts and latest diagnostic advancements regarding neuroendocrine tumors of the gynecologic tract.","volume":"57","author":"Georgescu","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"R5-20260204","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bpobgyn.2011.05.010","article-title":"Pathology of mixed M\u00fcllerian tumours.","volume":"25","author":"D\u2019Angelo","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R6-20260204","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s41379-022-01160-1","article-title":"Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors.","volume":"35","author":"Momeni Boroujeni","year":"2022","journal-title":"Mod Pathol"},{"key":"R7-20260204","doi-asserted-by":"crossref","first-page":"837004","DOI":"10.3389\/fimmu.2022.837004","article-title":"High-grade endometrial stromal sarcoma: molecular alterations and potential immunotherapeutic strategies.","volume":"13","author":"Kim","year":"2022","journal-title":"Front Immunol"},{"key":"R9-20260204","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ygyno.2019.09.004","article-title":"Neuroendocrine carcinoma of the endometrium: disease course, treatment, and outcomes.","volume":"155","author":"Schlechtweg","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R10-20260204","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/PAS.0000000000000633","article-title":"Neuroendocrine carcinoma of the endometrium: a clinicopathologic study of 25 cases.","volume":"40","author":"Pocrnich","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R11-20260204","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ygyno.2007.07.070","article-title":"A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus.","volume":"107","author":"Wolfson","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R12-20260204","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3390\/cancers14020354","article-title":"Therapeutic challenges in patients with gynecologic carcinosarcomas: analysis of a multicenter national cohort study from the french prospective TMRG network.","volume":"14","author":"Romeo","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R13-20260204","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5152\/balkanmedj.2016.151268","article-title":"Predictive and prognostic factors in ovarian and uterine carcinosarcomas.","volume":"33","author":"Cicin","year":"2016","journal-title":"Balkan Med J"},{"key":"R14-20260204","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ygyno.2015.09.002","article-title":"A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma.","volume":"139","author":"Dickson","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"9 Suppl 3","key":"R15-20260204","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/IGC.0000000000000228","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.","volume":"24","author":"Berton-Rigaud","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"R16-20260204","doi-asserted-by":"crossref","first-page":"11795549211056273","DOI":"10.1177\/11795549211056273","article-title":"Cervical carcinosarcoma: current understanding on pathogenesis, diagnosis, management and future perspectives.","volume":"15","author":"Shu","year":"2021","journal-title":"Clin Med Insights Oncol"},{"key":"R17-20260204","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1200\/JCO.21.02050","article-title":"Randomized Phase III trial of paclitaxel and carboplatin versus paclitaxel and ifosfamide in patients with carcinosarcoma of the uterus or ovary: an NRG Oncology Trial.","volume":"40","author":"Powell","year":"2022","journal-title":"J Clin Oncol"},{"key":"R18-20260204","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3390\/cancers14071835","article-title":"Neuroendocrine neoplasms of the gynecologic tract.","volume":"14","author":"Virarkar","year":"2022","journal-title":"Cancers (Basel)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T14:00:26Z","timestamp":1770213626000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":17,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038800","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,12]]}}}